Transcatheter Embolization and Occlusion Devices | Market Insights | Asia Pacific (Supplemental) | 2023
COVID-19 pandemic has negatively impacted the Asia Pacific transcatheter embolization and occlusion device market, but the impact of COVID-19 is limited and short term, the market will expand at a strong rate over the forecast period due to various driving factors such as growing adoption of minimally invasive treatment option such as embolization, increasing product launches, and adoption of advanced TEO devices supported by favorable clinical trial results.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for TEO devices in the Asia Pacific region from 2019 through 2031.